IRIDEX Corporation

IRIX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.65

+$0.01 (+1.09%)

Sep 22, 2026, 12:03 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.09%

(1D)

Rating

Updated: Sep 8, 2026

19.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $11.27M

1D Range

0.65 0.67

52W Range

0.61 1.65

Valuation (TTM)

PE -3.20

PB 3.06

EV/EBITDA -3.91

Valuation (NTM)

Forward PE 28.23

Forward PEG 0.03

Price Target $2.75

Cash Flow

FCF Yield -15.9%

SBC Adj. FCF Yield -22.4%

SBC Impact -41.2%

Margins

Gross Margin 36.2%

Operating Margin -5.4%

FCF Margin -3.4%

Growth (CAGR)

Revenue 3Y | 5Y -2.9% | 2.1%

Dil EPS 3Y | 5Y 58.0% | 20.2%

FCF 3Y | 5Y 44.9% | 25.8%

Returns

ROA -13.0%

ROE -78.9%

ROIC -19.5%

Financial Health

Net Cash

$4.46M

Current Ratio 1.82

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools ...

Sector Healthcare

Industry Medical - Devices

Employees 93

IPO Date Feb 15, 1996

Website www.iridex.com

Fiscal Year February - January

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 17, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞